Treasury intervention sparks rate relief... And Moderna’s cancer moonshot 8/19/26

The Treasury’s decision to double debt buybacks has triggered significant market volatility, driving a sharp decline in the dollar and fueling rallies in gold and Bitcoin as investors adjust to potential bond market stabilization. Target’s strong earnings and improved guidance suggest a retail turnaround, though persistent inflation and high interest rates continue to pressure consumer affordability. In the technology sector, the battle for AI supremacy intensifies, with OpenAI facing growth scrutiny relative to Anthropic, while Google’s custom chip partnership with Marvell underscores a broader trend toward vertical integration. Meanwhile, Moderna and Merck’s promising cancer vaccine trial results have propelled healthcare stocks to record highs. Simultaneously, China’s rapid advancement in humanoid robotics, exemplified by Unitree’s market debut, highlights a strategic arms race in physical AI that challenges U.S. dominance in leading-edge technology.